Programme for UBD-Snibe Symposium 2026

best viewed on desktop

last updated 02/06/2026

.

contact informationubdsnibe2026@ubd.edu.bn

Symposium Theme: Advances in Clinical Chemistry & Immunoassay Technologies

20 - 21 June 2026

Day 1 Scientific Foundations and Clinical Translation

Plenary Session 1 - Advances in Immunoassay Technologies and Laboratory Automation

This session introduces participants to key developments in immunoassay technologies and laboratory automation that underpin routine diagnostic testing. It focuses on improvements in assay performance, analytical quality, workflow efficiency, and the integration of automation into clinical laboratories. The session is educational in nature, linking technological innovation to practical laboratory application.

Panel Discussion - Translating Diagnostic Innovation into Clinical Impact

The panel discussion brings together representatives from industry, clinical laboratories, professional bodies, and academia to explore how diagnostic innovations are adopted and implemented in real-world healthcare settings. Moving beyond technical details, the discussion highlights the challenges, opportunities, and practical considerations involved in translating diagnostic advances into routine practice, particularly within small- and medium-sized healthcare systems.

Technology Spotlight - Beyond Automation Towards Excellence: Advancing Laboratory Diagnostics Through Innovation

The session will focus on contemporary clinical chemistry and immonoassay platforms, with particular emphasis on the MAGLUMI portfolio of chemiluminescence immunoassay (CLIA) platforms and its application in routine clinical chemistry workflows. Through presentation and discussion of current diagnostic challenges and technological innovations, participants will gain insight into how automated CLIA platforms contribute to workflow optimisation, analytical performance and improved clinical outcomes.

Programme Overview

Day 2 Diagnostics in Practice, Workforce and Innovation

Plenary Session 2 - Diagnostics for Non-Communicable Diseases: From Screening to Monitoring

This session explores the role of diagnostics in managing non-communicable diseases (NCDs), which pose a significant health burden in Brunei Darussalam and the region. It highlights how laboratory testing supports early detection, risk stratification, and long-term disease monitoring. The plenary combines national clinical and policy perspectives with insights from diagnostic technology, emphasising the link between laboratory data and patient care.

Plenary Session 3 - Laboratory Quality, Standards and Workforce Development

This session focuses on the systems and people that support reliable diagnostic services. Topics include laboratory quality assurance, accreditation, professional standards, and workforce training and sustainability. The session underscores the importance of maintaining high standards and developing a future-ready laboratory workforce to support evolving diagnostic technologies.

Important Dates

Abstract submission is extended and closes on Sunday, 31 May 2026. Click [here] for abstract guidelines.

Registration closes on Friday, 12 June 2026. Click [here] to reach the registration page.